SAN FRANCISCO, Nov. 7 – Paradigm Genetics on Wednesday posted third-quarter revenues of $6.3 million versus $3.5 for the same quarter a year ago, the company announced.

The Research Triangle Park, N.C.-based company attributed the revenue rise to output related to partnerships with Bayer and Monsanto.

Total operating expenses for the period increased 31 percent to $10.2 million from $7.8 million for the year-ago period.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.